attachment
attachment

all rights answer

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources

ASSIGNMENT 5 - COMPLETE ANSWERS

C.U. Shah Medical College | Second MBBS | Pathology | 2025


SECTION - I


Q.1 - A 60-year-old man: Proteinuria + 35% Plasma Cells in Bone Marrow + Apple Green Birefringence on Congo Red [10 marks]


1) Probable Diagnosis (1 mark)

Multiple Myeloma with AL (Primary) Amyloidosis
The triad of:
  • Proteinuria (Bence-Jones protein / nephrotic syndrome from amyloid kidney deposits)
  • Bone marrow showing 35% plasma cells (>10% confirms Multiple Myeloma)
  • Tissue biopsy: Congo red stain + apple green birefringence under polarized light = classic Amyloid deposit
This is Primary/AL Amyloidosis arising from the plasma cell dyscrasia of Multiple Myeloma.

2) Definition of Amyloidosis (1 mark)

Amyloidosis is a pathological condition characterized by extracellular deposition of fibrillar proteinaceous material (amyloid) derived from misfolded proteins in various organs and tissues, leading to progressive organ dysfunction. The deposited fibrils have a beta-pleated sheet configuration, which confers resistance to proteolysis and gives apple green birefringence on Congo red staining under polarized light.

3) Classification of Amyloidosis (2 marks)

A. Based on Distribution:
TypeDescription
Systemic (Generalized)Affects multiple organs
LocalizedConfined to one organ/tissue
B. Based on Precursor Protein (Biochemical Classification):
TypePrecursor ProteinAssociated Condition
AL (Primary)Immunoglobulin light chains (lambda/kappa)Multiple Myeloma, Monoclonal Gammopathy
AA (Secondary)Serum Amyloid A (SAA) protein - liver-derivedChronic inflammation (TB, RA, Osteomyelitis, Crohn's)
ATTRwt (Senile Systemic)Wild-type Transthyretin (TTR)Old age, cardiac amyloidosis (males >70 yrs)
ATTRv (Familial)Variant/mutant TransthyretinFamilial amyloid polyneuropathy
Aβ2mβ2-microglobulin (MHC class I component)Long-term hemodialysis
Amyloid Precursor Protein (APP)Alzheimer disease
LocalizedVarious (e.g., amylin/AIAPP)Islets of Langerhans in Type 2 DM

4) Pathogenesis of Amyloidosis (3 marks)

Core Mechanism: Protein Misfolding and Aggregation
  1. Step 1 - Increased production of amyloidogenic protein:
    • In AL amyloidosis: monoclonal plasma cells in Multiple Myeloma produce excess free immunoglobulin light chains (lambda > kappa)
    • In AA amyloidosis: chronic inflammation drives liver to produce excess SAA protein (acute-phase reactant)
  2. Step 2 - Protein misfolding:
    • Normally, misfolded proteins are degraded intracellularly via proteasomes or extracellularly by macrophages
    • In amyloidosis, these quality-control mechanisms fail
    • The proteins misfold into a beta-pleated sheet conformation
  3. Step 3 - Fibrillogenesis:
    • Misfolded monomers aggregate to form oligomers, then protofibrils, then mature amyloid fibrils
    • Seeding effect: once fibrils form, they act as templates (seeds) for further fibril growth, accelerating deposition
  4. Step 4 - Extracellular deposition:
    • Fibrils deposit in extracellular spaces, often along basement membranes
    • Associated proteins: Serum Amyloid P (SAP) component, Apolipoprotein E, heparan sulfate proteoglycans - these stabilize fibrils and protect against degradation
  5. Step 5 - Organ damage:
    • Mechanical disruption of tissue architecture
    • Some amyloidogenic proteins activate signaling pathways that increase ROS production and impair mitochondrial function
    • Result: progressive organ dysfunction (nephrotic syndrome, cardiomyopathy, hepatomegaly, neuropathy)
Diagram:
Plasma Cells (Multiple Myeloma)
        ↓ Excess light chains
Protein Misfolding → Beta-pleated sheet configuration
        ↓
Fibril Formation (seeded polymerization)
        ↓
Extracellular Deposition in tissues
        ↓
Congo red (+) → Apple green birefringence (polarized light)

5) Morphology of Amyloidosis in Different Tissues - Any TWO (3 marks)

A. KIDNEY (most commonly affected in AL and AA amyloidosis):
  • Gross: Kidneys are enlarged, pale, waxy, "large white kidney." In advanced disease, contracted kidneys may be seen.
  • Microscopy (H&E): Amorphous, eosinophilic, hyaline material deposits in:
    • Mesangium of glomeruli (earliest and most prominent)
    • Along glomerular capillary walls (GBM)
    • Interstitium and tubular basement membranes
    • Walls of arterioles
  • Congo red stain: Pink-red color; apple green birefringence under polarized light
  • Consequence: Proteinuria → Nephrotic syndrome → Renal failure
B. SPLEEN: Two patterns:
  • Sago spleen: Amyloid deposits in the lymphoid follicles (white pulp) → appear as small, grayish, translucent nodules resembling sago grains (tapioca-like appearance)
  • Lardaceous (Bacon) spleen: Diffuse deposits in the splenic sinusoids/red pulp → large, firm, waxy spleen with a "lard-like" appearance on cut section
  • Both patterns: Congo red positive, apple green birefringence
C. LIVER (for reference):
  • Gross: Enlarged, firm, pale, waxy liver ("lardaceous liver")
  • Microscopy: Amyloid deposits in Space of Disse (between hepatocytes and sinusoidal endothelium), eventually compressing hepatocytes
  • Hepatomegaly + mild liver dysfunction; rarely liver failure

Q.2 - Short Notes - ANY THREE (3×5 = 15 marks)


Q.2.1 - Define Metastasis; Describe Mechanism and Biology of Invasion and Metastasis (1+4)

Definition: Metastasis is the spread of malignant tumor cells from the primary site to distant, non-contiguous tissues/organs to form secondary tumor deposits. It is the hallmark of malignancy and the most common cause of cancer-related mortality.
Biology and Mechanism of Invasion and Metastasis (The Metastatic Cascade):
Step 1 - Local Invasion:
  • Malignant cells lose cell-cell adhesion (downregulation of E-cadherin) and cell-ECM adhesion
  • Tumor cells secrete matrix metalloproteinases (MMPs) - especially MMP-2 and MMP-9 - and serine proteases that degrade basement membrane and ECM
  • Epithelial-Mesenchymal Transition (EMT): tumor cells acquire a mesenchymal phenotype - fibroblast-like, motile, invasive
    • Key transcription factors: Snail, Twist, ZEB1 - suppress E-cadherin, upregulate vimentin
  • Actin cytoskeleton remodeling drives formation of lamellipodia and invadopodia for directional migration
Step 2 - Intravasation:
  • Tumor cells penetrate blood vessels or lymphatics (lymphatics easier to invade)
  • Vascular permeability is increased by tumor-secreted VEGF
  • Most intravasated cells are killed by immune surveillance (NK cells, cytotoxic T cells)
Step 3 - Survival in Circulation:
  • Circulating Tumor Cells (CTCs) are vulnerable to shear forces, anoikis, and immune attack
  • Tumor cells may travel as clusters (homo-aggregates) or associate with platelets for protection
Step 4 - Arrest and Extravasation:
  • Cells arrest at distant capillary beds, often due to size or specific receptor-ligand interactions
  • Organ tropism (seed and soil hypothesis - Paget, 1889):
    • "Seed" = tumor cell
    • "Soil" = favorable organ microenvironment
    • E.g., breast cancer → bone (via CXCR4-CXCL12 axis), prostate → bone, colon → liver
Step 5 - Formation of Metastatic Colony:
  • Extravasated cells must adapt to new microenvironment
  • Some enter dormancy (micrometastasis); others proliferate
  • Neo-angiogenesis required for growth beyond 1-2 mm
Routes of Metastasis:
RouteCommon Cancers
LymphaticCarcinomas (breast, colon, lung) - to regional lymph nodes
HematogenousSarcomas, also carcinomas - liver, lungs, bone, brain
TranscoelomicOvarian, colonic - peritoneal spread
PerineuralProstate, pancreatic
Direct (implantation)Surgical seeding

Q.2.2 - Describe Morphological Forms of Reversible Cell Injury

Definition: Reversible cell injury = derangement of function and morphology that cells can recover from if the damaging stimulus is removed.
Two Main Morphological Patterns:
A. Cellular Swelling (Hydropic Change / Vacuolar Degeneration):
  • Most common and earliest sign of cell injury
  • Mechanism: Failure of Na+/K+ ATPase pump (due to ATP depletion, toxins, hypoxia) → Na+ and water accumulate intracellularly → cell swelling
  • Gross: Organ appears enlarged, pale, with increased weight
  • LM (Light Microscopy):
    • Cells are enlarged
    • Cytoplasm shows small, clear vacuoles (pinched-off segments of ER) - "vacuolar degeneration"
    • Nucleus is normal or slightly enlarged
  • EM (Electron Microscopy):
    • Plasma membrane blebbing (blebs/bullae)
    • ER swelling and ribosome detachment
    • Mitochondria swelling with small densities
    • Nuclear chromatin clumping
B. Fatty Change (Steatosis):
  • Intracellular accumulation of neutral lipid (triglycerides) in non-adipose cells
  • Most commonly seen in: Liver (most important), heart, kidney
  • Causes: Alcoholism, protein malnutrition, diabetes, hypoxia, toxins (CCl4)
  • Mechanism in liver:
    • Excess FFAs delivered to liver
    • Increased fatty acid synthesis
    • Decreased beta-oxidation
    • Decreased apoprotein synthesis (↓ VLDL export) → All lead to triglyceride accumulation
  • Gross (Liver): Enlarged, yellow ("yellow liver"), greasy, soft
  • LM: Hepatocytes contain clear vacuoles of variable size
    • Microvesicular steatosis: Multiple small droplets, nucleus central (e.g., acute fatty liver of pregnancy)
    • Macrovesicular steatosis: Large single vacuole pushes nucleus to periphery (e.g., alcoholic liver disease)
  • Special stains: Oil Red O (frozen sections) = red; Sudan IV = red
Reversibility criteria: If stimulus removed before membrane damage becomes irreversible, cells recover. Key point of no return = massive calcium influx + outer mitochondrial membrane permeabilization.

Q.2.3 - Wound Healing (Burn case: A 39-year-old man, large surface burn - heals in 3 weeks without surgery)

This scenario describes healing by secondary intention (large wound) ultimately achieving complete healing - a superficial enough burn (partial thickness) allowing re-epithelialization.
A. Sequence of Wound Healing in Above Scenario (3 marks):
Phase 1 - Hemostasis and Inflammation (Day 0-3):
  • Blood clot (fibrin + platelets) forms immediately
  • Platelets release: PDGF, TGF-β, TGF-α, EGF → initiate healing
  • Vasoconstriction (minutes) → vasodilation → increased permeability
  • Day 1-2: Neutrophils infiltrate (clean debris, bacteria)
  • Day 2-3: Macrophages arrive and dominate - most important cells for wound healing
    • Release: IL-1, TNF, FGF, VEGF, TGF-β, PDGF
    • Phagocytose debris and apoptotic neutrophils
Phase 2 - Proliferation / Granulation Tissue (Day 3-5 to 3 weeks):
  • Angiogenesis: New capillary sprouts form (VEGF, FGF-2 driven)
  • Fibroplasia: Fibroblasts proliferate and migrate in
    • Produce collagen (initially type III, immature)
    • Produce fibronectin, proteoglycans
  • Granulation tissue = new blood vessels (pink) + loose ECM + macrophages, fibroblasts
    • Hallmark: "granular" pink appearance
  • Myofibroblasts (derived from fibroblasts): contract wound edges - wound contraction
  • Re-epithelialization: Keratinocytes from wound edges and adnexal structures (hair follicles, sweat glands) migrate across the wound surface
    • In partial-thickness burns: adnexal structures preserved → complete re-epithelialization possible without skin grafts (explains 3-week healing without surgery)
Phase 3 - Remodeling / Scar Maturation (Week 3 - months/years):
  • Type III collagen replaced by type I (stronger, more organized)
  • Cross-linking of collagen fibers increases tensile strength
  • Collagenases (MMPs) and their inhibitors (TIMPs) balance matrix remodeling
  • Vascularity decreases → scar becomes pale
  • Maximum tensile strength: ~70-80% of normal skin (never 100%)
B. Complications of Wound Healing (2 marks):
ComplicationDescription
InfectionMost common; delays healing, promotes excessive inflammation
Wound dehiscenceReopening of wound, especially abdominal; due to increased intra-abdominal pressure or poor nutrition
Incisional herniaDefect in abdominal wall after dehiscence
Hypertrophic scarRaised, red scar confined to wound margins; excessive collagen deposition; may regress
KeloidScar extends beyond wound margins (claw-like); does not regress; more common in dark-skinned individuals; more collagen type I and III, excess TGF-β
ContractureExcessive myofibroblast activity; especially in burns; can restrict movement across joints
Deficient scar (Ulceration)Inadequate granulation, poor vascularization (diabetes, venous stasis)
Desmoid tumorRare; fibromatosis arising in scar
Wound sinus/fistulaPersistent tract due to infection, foreign body

Q.2.4 - Enumerate Blood Components in Blood Bank; Advantages and Disadvantages of Fresh Frozen Plasma (1+4)

Blood Components Available in Blood Bank:
  1. Packed Red Blood Cells (pRBCs)
  2. Fresh Frozen Plasma (FFP)
  3. Platelet Concentrate (Random Donor Platelets / Single Donor Apheresis Platelets)
  4. Cryoprecipitate
  5. Cryopoor plasma (Cryosupernatant)
  6. Granulocyte concentrate
  7. Albumin (4% and 20%)
  8. Immunoglobulins (IVIG)
  9. Factor concentrates (Factor VIII, IX, etc.)
  10. Whole blood (rarely used)
Fresh Frozen Plasma (FFP):
  • Prepared from whole blood by centrifugation within 6-8 hours of collection and frozen at -18°C or below
  • Contains all coagulation factors (I, II, V, VII, VIII, IX, X, XI), fibrinogen, protein C, protein S, antithrombin
  • Volume: ~200-250 mL per unit; stored up to 12 months at -30°C
ADVANTAGESDISADVANTAGES
Contains ALL coagulation factors including labile factors V and VIIIRisk of transfusion-transmitted infections (HIV, HBV, HCV, syphilis)
Used in multiple coagulation factor deficiencies (DIC, liver disease, massive transfusion)Risk of transfusion-related reactions: TRALI (Transfusion-Related Acute Lung Injury) - most serious
Immediate reversal of warfarin anticoagulationTACO (Transfusion-Associated Circulatory Overload) - especially in elderly/cardiac patients
Source of plasma proteins (fibronectin, complement)Requires ABO compatibility (not group-specific in emergency but ideally matched)
Available in most blood banksRequires thawing (30-37°C, 20-30 min) - not instantly available
Can be used for plasmapheresis (TTP treatment)Large volume needed (15 mL/kg) to achieve hemostasis
Used in coagulopathies of liver diseaseFebrile non-hemolytic reactions possible
No cross-match required (only ABO typing needed)Alloimmunization possible
Short shelf life after thawing (use within 24 hours at 4°C)
Contains citrate → hypocalcemia with massive transfusion

Q.3 - Short Notes - ANY THREE (3×5 = 15 marks)


Q.3.1 - Enlist Tumour Suppressor Genes; Role of P53 in Tumorigenesis (1+4)

Tumour Suppressor Genes (Anti-oncogenes):
Genes that normally restrain cell growth; loss of function (both alleles = Knudson's two-hit hypothesis) leads to uncontrolled proliferation.
Major Tumour Suppressor Genes:
GeneChromosomeAssociated Tumor
RB1 (Retinoblastoma)13q14Retinoblastoma, Osteosarcoma
TP5317p13Most human cancers (>50%)
BRCA117qBreast, Ovarian carcinoma
BRCA213qBreast, Ovarian, Pancreatic
APC5q21Colorectal carcinoma (FAP)
NF117qNeurofibromatosis type 1
NF222qNeurofibromatosis type 2
VHL3p25Renal Cell Carcinoma
WT111p13Wilms tumor
PTEN10q23Breast, Prostate, Endometrial
CDKN2A (p16)9p21Melanoma, Pancreatic
SMAD2/SMAD418qColorectal, Pancreatic
Role of P53 in Tumorigenesis ("Guardian of the Genome"):
Normal P53 Functions:
  • P53 is a transcription factor (393 aa), encoded by TP53 gene on chromosome 17p13
  • Normally kept at low levels by MDM2 (an E3 ubiquitin ligase that tags p53 for proteasomal degradation)
Activation of P53: When cells suffer DNA damage, oncogene activation, hypoxia, or telomere shortening:
  1. ATM/ATR kinases are activated
  2. They phosphorylate P53 → P53 released from MDM2 → P53 accumulates
  3. P53 tetramerizes and acts as transcription factor
P53 Downstream Responses - The 4 Key Functions:
DNA Damage
    ↓
P53 Activation
    ↓
┌───────────────────────────────────────────────────┐
│ 1. Cell Cycle Arrest      │ 2. DNA Repair          │
│    (via p21 → inhibits    │    (GADD45, DDB2)      │
│    CDK4/6-Cyclin D)       │                        │
├───────────────────────────┼────────────────────────┤
│ 3. Apoptosis              │ 4. Senescence          │
│    (via BAX, PUMA, NOXA;  │    (permanent growth   │
│    downregulates BCL-2)   │    arrest)             │
└───────────────────────────────────────────────────┘
P53 in Tumorigenesis:
  1. Mutation: >50% of all human cancers have TP53 mutations; mostly missense mutations (gain-of-function) in the DNA-binding domain
  2. Without P53: DNA-damaged cells bypass arrest → continue dividing → accumulate further mutations → malignant transformation
  3. MDM2 amplification: In some tumors (especially sarcomas), MDM2 is overexpressed → degrades p53 without mutation
  4. HPV: E6 protein of high-risk HPV binds p53 and promotes its degradation (mechanism in cervical cancer)
  5. Li-Fraumeni Syndrome: Germline TP53 mutation → multiple cancers at young age (breast, sarcomas, brain tumors, leukemia)

Q.3.2 - 65-year-old Female: Black Discoloration of Foot and Lower Leg, Limb Pulsations Not Palpable, Sharp Line of Demarcation

A) Most Probable Diagnosis (1 mark):
Dry Gangrene (likely due to Peripheral Arterial Disease / Atherosclerosis)
The clinical features - black discoloration, absent pulsations, sharp line of demarcation - point to dry gangrene from arterial occlusion.
B) Etiological Factors (2 marks):
Primary Cause: Atherosclerosis of peripheral arteries (chronic progressive arterial insufficiency)
Risk Factors:
FactorDetails
Diabetes MellitusMost important cause of peripheral vascular disease and gangrene in elderly females; accelerates atherosclerosis + microangiopathy + neuropathy
HypertensionAccelerates atherosclerosis
SmokingVasoconstriction + endothelial damage + accelerated atherosclerosis
HyperlipidemiaFoam cell formation, plaque build-up
Buerger's disease(Thromboangiitis Obliterans) - though more in young male smokers
Arterial thrombosis/embolismAcute on chronic arterial occlusion
Raynaud's diseaseLess likely here
Old ageVessel calcification, reduced elasticity
C) Pathogenesis of Dry Gangrene (2 marks):
  1. Arterial occlusion (atherosclerotic plaque ± superimposed thrombosis) → severe ischemia
  2. Ischemia > repair capacity → cells undergo coagulative necrosis
  3. Dehydration/desiccation of tissues: slow arterial occlusion allows time for:
    • Venous drainage to remain intact (initially)
    • Fluid drains out → tissues become dry, shrunken, mummified
  4. Coagulative necrosis predominates:
    • Proteins coagulate
    • Tissue becomes firm, hard, blackened (due to iron sulfide from hemoglobin breakdown - FeS)
  5. Sharp line of demarcation:
    • Inflammatory reaction between viable and necrotic tissue
    • Hyperemia of living tissue vs. black necrotic tissue
  6. No infection (or minimal): dry, avascular tissue is unfavorable for bacterial growth
  7. If infection supervenes → Dry gangrene converts to Wet gangrene

Q.3.3 - Enumerate and Describe Chemical Mediators in Acute Inflammation (1+4)

Classification of Chemical Mediators:
A. Cell-Derived Mediators:
MediatorSourceMain Actions
HistamineMast cells, basophils, plateletsEarly vasodilation, increased vascular permeability, bronchoconstriction
SerotoninPlateletsVasodilation, increased permeability
Prostaglandins (PGI2, PGE2, PGD2)Arachidonic acid (COX pathway) from mast cells, macrophagesVasodilation, pain (sensitize nociceptors), fever (PGE2 acts on hypothalamus)
Leukotrienes (LTC4, LTD4, LTE4 = slow-reacting substances; LTB4)Arachidonic acid (LOX pathway)LTB4: potent chemotaxis for neutrophils; LTC4/D4/E4: bronchoconstriction, mucus secretion, increased permeability
PAF (Platelet Activating Factor)Mast cells, basophils, neutrophils, endotheliumPlatelet aggregation, bronchoconstriction, vasodilation, chemotaxis
Reactive Oxygen Species (ROS)Neutrophils, macrophages (NADPH oxidase)Bacterial killing, tissue damage, PMN recruitment
Nitric Oxide (NO)Endothelium (eNOS), macrophages (iNOS)Vasodilation, bactericidal, reduces platelet aggregation
Lysosomal enzymesNeutrophils, macrophagesTissue destruction, killing of microbes
Cytokines: IL-1, TNF-αMacrophagesFever, acute-phase response, leukocyte activation, ICAM/VCAM expression
IL-8 (CXCL8)Macrophages, endotheliumPotent neutrophil chemotaxis
B. Plasma-Derived Mediators:
SystemMediatorsActions
Complement SystemC3a, C5a (anaphylatoxins); C5b-9 (MAC); C3b (opsonin)C3a/C5a: mast cell degranulation, chemotaxis; MAC: cell lysis
Kinin SystemBradykininPain, vasodilation, increased permeability
Coagulation SystemThrombin, fibrin split products, Factor XaPlatelet aggregation, fibrin formation
Fibrinolytic SystemPlasminComplement activation, fibrin cleavage
Key Points:
  • Vasodilation: Histamine, NO, PGI2, PGE2, bradykinin
  • Increased Permeability: Histamine, C3a/C5a, LTC4/D4, bradykinin, substance P
  • Chemotaxis: LTB4, C5a, IL-8, bacterial products (fMLP)
  • Fever: IL-1, TNF-α, IL-6 (endogenous pyrogens) → induce COX-2 in hypothalamus → PGE2 → raises temperature set point

Q.3.4 - Define Embolism; Types of Embolism; Fat Embolism in Brief (1+1+3)

Definition of Embolism: Embolism is the process of partial or complete obstruction of a blood vessel by a mass (embolus) that has been carried there by the bloodstream. The embolus is a detached intravascular solid, liquid, or gaseous mass that travels from its site of origin to a distant site.
Types of Embolism:
  1. Thromboembolism (most common - 99%)
    • Pulmonary thromboembolism (from DVT)
    • Systemic arterial embolism (from left heart mural thrombus, vegetations)
  2. Fat embolism
  3. Air/Gas embolism
  4. Amniotic fluid embolism
  5. Tumor embolism (neoplastic cells)
  6. Bone marrow embolism
  7. Foreign body embolism (catheter fragments, talc in IV drug users)
  8. Septic embolism (infected thrombus)
  9. Nitrogen gas embolism (decompression sickness / caisson disease / bends)
  10. Paradoxical embolism (venous embolus crosses to arterial via ASD/VSD)
Fat Embolism:
Definition: Occlusion of blood vessels by fat globules in the circulation.
Causes:
  • Long bone fractures (femur, tibia) - most common - marrow fat released
  • Severe burns, crush injuries, pancreatitis
  • Liposuction, orthopedic surgery
  • Sickle cell disease (bone marrow necrosis)
Pathogenesis (Two theories):
  1. Mechanical theory: Fat globules from marrow of fractured long bones directly enter torn venules → travel to pulmonary capillaries → obstruct them
  2. Biochemical theory: Stress-induced catecholamines mobilize free fatty acids from adipose tissue → coalesce into fat globules → also toxic injury to pneumocytes and endothelium
Fat Embolism Syndrome (FES):
  • Develops 1-3 days after injury
  • Classic triad:
    1. Respiratory: Dyspnea, hypoxemia, ARDS-like picture (fat in pulmonary capillaries)
    2. Neurological: Confusion, stupor, coma ("shower embolization" to cerebral vessels)
    3. Petechiae: Especially on upper chest, conjunctiva, axilla (fat globules in dermal capillaries)
  • Lab: Fat globules in urine (lipiduria), thrombocytopenia, anemia
  • CXR: "Snowstorm" pattern
  • Treatment: Supportive; oxygen, steroids (controversial); prophylaxis with early fracture fixation

Q.4 - Short Notes - ANY FIVE (2×5 = 10 marks)


Q.4.1 - Difference Between Red Infarct and White Infarct

FeatureRed (Hemorrhagic) InfarctWhite (Pale/Anemic) Infarct
Blood flowDual blood supply or venous occlusionEnd-arterial (single) blood supply
Typical organsLung, intestine, ovary, testis, brainHeart (myocardium), spleen, kidney
MechanismRe-perfusion of necrotic tissue; collateral vessels allow blood seepage into necrotic areaNo collaterals; blood supply completely cut off; no seepage
Appearance (Gross)Red, hemorrhagic, soft, spongyPale/white/yellow, firm, wedge-shaped
ShapeMay be irregularTypically wedge-shaped with base on surface
BorderHyperemic rim presentHyperemic rim / hemorrhagic zone around pale center
ConsistencySoft initiallyFirm (coagulative necrosis)
Common causeVenous thrombosis (intestine/ovary); pulmonary embolism with congestionArterial thrombosis/embolism
MicroscopyCoagulative necrosis + flooded with RBCsCoagulative necrosis (shadow outline of cells, no RBCs)
ExamplePulmonary infarct after PE, hemorrhagic cerebral infarctMI, splenic infarct, renal infarct

Q.4.2 - Contribution of Rudolf Virchow in Field of Pathology

Rudolf Virchow (1821-1902) - "Father of Modern Pathology" / "Pope of Medicine"
  1. Cellular Pathology (1858): Published "Cellularpathologie" - established that all disease arises from pathological changes in cells ("Omnis cellula e cellula" - every cell from a pre-existing cell). Replaced humoral theory.
  2. Virchow's Triad (1856): Identified three factors predisposing to thrombosis:
    • Endothelial injury
    • Abnormal blood flow (stasis/turbulence)
    • Hypercoagulability (blood constituents) Still forms the basis of thrombosis understanding.
  3. Leukemia: First described and named leukemia (1845) - observed "white blood" in two patients.
  4. Embolism and Thrombosis: Distinguished between thrombus and embolus; coined the term "embolism."
  5. Virchow's Node (Troisier's sign): Left supraclavicular lymph node enlargement in gastric/abdominal cancer - bears his name.
  6. Gliosis: Described reactive gliosis in the nervous system.
  7. Amyloid: Coined the term "amyloid" (1854) - thought the deposits were starch-like (amylose = starch) due to iodine staining.
  8. Fibrin: Described fibrinous exudates and their organization.
  9. Anthropology/Public Health: Pioneered social medicine, emphasized the role of social conditions in disease; improved Berlin's public health infrastructure.
  10. Described many entities: Virchow-Robin spaces (perivascular spaces in brain), chromatin, chordoma, etc.

Q.4.3 - Enumerate Cardinal Signs of Acute Inflammation

The cardinal signs were classically described by Celsus (4 signs) and later Virchow added the 5th:
#LatinEnglishMechanism
1RuborRednessVasodilation → increased blood in area → erythema
2CalorHeatVasodilation → increased warm arterial blood to periphery
3TumorSwellingIncreased vascular permeability → exudate in tissue = edema
4DolorPainSensitization of nociceptors by bradykinin, prostaglandins (PGE2), serotonin
5Functio laesaLoss of functionAdded by Virchow; result of pain + swelling + tissue damage
Mediators responsible:
  • Rubor + Calor: Histamine, NO, PGI2, PGE2 (vasodilation)
  • Tumor: Histamine, C3a/C5a, bradykinin (increased permeability)
  • Dolor: Bradykinin (direct), PGE2/PGI2 (sensitize C-fibers), substance P

Q.4.4 - Define Paraneoplastic Syndrome; Two Examples

Definition: Paraneoplastic syndromes are symptom complexes in cancer-bearing patients that cannot be explained by local invasion, metastasis, or metabolic effects of the tumor itself (e.g., obstruction, nutrition depletion). They are caused by:
  • Ectopic secretion of hormones or hormone-like substances by tumor
  • Immune-mediated cross-reactions (antibodies/T cells against tumor antigens that also target normal tissues)
Significance:
  • May be the first sign of an occult neoplasm
  • Can mimic metastasis
  • May cause significant morbidity
  • Do not reflect prognosis but indicate presence of cancer
Two Examples:
1. Hypercalcemia of Malignancy (Humoral Hypercalcemia of Malignancy - HHM):
  • Tumor: Squamous cell carcinoma of lung, Breast cancer, Renal cell carcinoma, Multiple myeloma
  • Mechanism: Tumor secretes PTHrP (PTH-related Protein) → mimics PTH → increases bone resorption, renal calcium reabsorption → hypercalcemia
  • Symptoms: Weakness, confusion, polyuria, constipation, bone pain
2. SIADH (Syndrome of Inappropriate ADH secretion):
  • Tumor: Small cell carcinoma of lung (most common)
  • Mechanism: Tumor ectopically secretes ADH (vasopressin) → excess water reabsorption → dilutional hyponatremia
  • Symptoms: Confusion, seizures, lethargy (hyponatremia)
Other examples for knowledge:
  • Cushing syndrome: Ectopic ACTH secretion (small cell lung cancer)
  • Eaton-Lambert syndrome: Antibodies against voltage-gated Ca2+ channels (small cell lung cancer) → proximal muscle weakness
  • Cerebellar degeneration: Anti-Yo antibodies (ovarian/breast cancer)
  • Acanthosis nigricans: Gastric cancer
  • DVT (Trousseau syndrome): Mucin-secreting carcinomas (pancreas, GI)

Q.4.5 - Name Various Blood Group Systems; Brief about Bombay Blood Group

Major Blood Group Systems:
SystemGene/Chromosomal BasisAntigens
ABOChromosome 9; glycosyltransferasesA, B, H antigens on RBC
Rh (Rhesus)Chromosome 1; RHD/RHCE genesD, C, c, E, e antigens; D most important
KellChromosome 7; KEL geneK (Kell), k (Cellano) - highly immunogenic
DuffyChromosome 1; DARC geneFy^a, Fy^b
KiddChromosome 18; SLC14A1 geneJk^a, Jk^b
LewisChromosome 19; FUT3 geneLe^a, Le^b
MNSChromosome 4; GYPA/GYPBM, N, S, s
PChromosome 22P1, P2, p
LutheranChromosome 19Lu^a, Lu^b
I/iChromosome 6; GCNT2I, i
HLAChromosome 6HLA antigens (on WBCs/platelets primarily)
Bombay (Oh)FUT1 gene mutationAbsent H antigen
Bombay Blood Group (Oh / hh phenotype):
  • Discovered: 1952 in Bombay (Mumbai) by Bhende et al.
  • Incidence: Extremely rare - 1 in 10,000 in India; 1 in 1,000,000 in Europe
  • Genetics: Homozygous mutations in FUT1 gene (H gene) on chromosome 19
    • Normally FUT1 encodes H-transferase enzyme that adds fucose to form H antigen on RBC surface
    • H antigen is the precursor for A and B antigens
    • In Bombay phenotype: no H antigen formed → no A or B antigens formed either
Key Features:
FeatureBombay Blood Group
Antigens on RBCNone (no H, A, or B)
Antibodies in serumAnti-H, Anti-A, Anti-B (all IgM, naturally occurring)
Compatible bloodOnly other Bombay (Oh) blood
ABO typingAppears as group O (false grouping)
Cross-matchIncompatible with ALL ABO groups including O
Transfusion significanceCan receive only Bombay blood; any other blood causes severe hemolytic reaction
Secretor statusAlways non-secretors for H
InheritanceAutosomal recessive
Clinical significance:
  • Bombay individuals appear to be group O on forward typing but anti-H reaction reveals true identity
  • Pre-operative planning: store autologous blood or identify Bombay donors
  • Anti-H causes severe, potentially fatal intravascular hemolytic transfusion reaction

Q.4.6 - What is Pyroptosis? Two Differences Between Pyroptosis and Apoptosis

Pyroptosis:
Pyroptosis (from Greek: pyro = fire/fever; ptosis = falling) is a form of programmed, inflammatory cell death characterized by:
  • Activation of inflammasomes (intracellular protein complexes)
  • Activation of Caspase-1 (and Caspase-4/5 in humans) and Caspase-11 (in mice)
  • Cleavage of Gasdermin D (GSDMD) → N-terminal fragment inserts into plasma membrane → forms pores
  • Cell swelling, osmotic lysis, plasma membrane rupture
  • Release of IL-1β, IL-18 (pro-inflammatory cytokines) and DAMPs (HMGB1)
  • Morphologically: cell swelling (not shrinkage), plasma membrane disruption, nuclear damage
Mechanism:
Pathogen / PAMPs / DAMPs
        ↓
Inflammasome Assembly (NLRP3, AIM2, NLRC4)
        ↓
Caspase-1 Activation
        ↓
1. Cleavage of Gasdermin D → Pore formation → Cell lysis + cytokine release
2. Cleavage of pro-IL-1β → mature IL-1β (released through pores)
3. Cleavage of pro-IL-18 → mature IL-18
Two Differences Between Pyroptosis and Apoptosis:
FeaturePyroptosisApoptosis
Inflammatory naturePRO-INFLAMMATORY; releases IL-1β, IL-18, DAMPs; causes inflammationNON-INFLAMMATORY (silent cell death); contents packaged into apoptotic bodies; phagocytosed without inflammation
Membrane integrityPlasma membrane DISRUPTED early (gasdermin pores → cell lysis); cellular contents releasedPlasma membrane remains INTACT; cells shrink (not swell); apoptotic bodies formed; no contents spilled
Key caspasesCaspase-1, 4, 5, 11 (inflammatory caspases) + Gasdermin D cleavageCaspase-3, 7 (executioner); Caspase-8/9 (initiators); no gasdermin
MorphologyCell swelling, pore formation, osmotic lysisCell shrinkage, chromatin condensation, nuclear fragmentation, apoptotic bodies
Physiological roleDefense against intracellular pathogens (bacteria, viruses)Normal tissue homeostasis, development, removal of autoreactive lymphocytes

SECTION - II

(Note: Section II is partially visible in the image. Based on visible text:)
Q.5 (partially visible): Patient presented with easy fatigability, loss of appetite, pallor. Hemoglobin (Hb) mentioned as (CH)- 20. [This appears to be a hematology/anemia case]
Probable Diagnosis: Based on "easy fatigability, loss of appetite, pallor" + low Hb in a likely female patient = Iron Deficiency Anemia (most common), or could be Anemia of Chronic Disease or Megaloblastic Anemia depending on complete data (MCV, peripheral smear).

Q. (15 marks - partially visible): Disease (likely asking about a specific disease with 2.5+2.5 marks sub-question)

Q. - 25-Year-old Male: Headache, Convulsion; CSF Analysis Shows Plenty of Neutrophils:
A) Most Probable Diagnosis: Acute Bacterial (Pyogenic) Meningitis
  • CSF findings: Plenty of neutrophils (pleocytosis - PMN dominant) = hallmark of bacterial meningitis
  • Headache + Convulsions = features of meningeal irritation + raised ICP
Differential by Age (25-year-old):
  • Neisseria meningitidis (most common in young adults)
  • Streptococcus pneumoniae
  • Listeria monocytogenes (immunocompromised)
Complete CSF Findings in Bacterial Meningitis:
ParameterNormalBacterial Meningitis
AppearanceClearTurbid/Purulent
Pressure70-180 mmH2OElevated
WBC<5 lymphocytes100-10,000+ neutrophils
Protein15-45 mg/dLElevated (>100 mg/dL)
Glucose50-80 mg/dLLow (<40 or <2/3 serum)
Gram stainNegativePositive (60-90%)
Pathology:
  • Leptomeninges (pia + arachnoid) show acute inflammation
  • Subarachnoid space filled with neutrophilic exudate
  • Vascular congestion, cerebral edema
  • Gross: "pus over the brain surface"
  • Complications: hydrocephalus, cerebral abscess, subdural empyema, septicemia, DIC

Robbins, Cotran & Kumar Pathologic Basis of Disease and Robbins & Kumar Basic Pathology were the primary textbook references used throughout these answers.

Note: All answers above are based on standard Second MBBS Pathology curriculum. Key diagrams mentioned should be drawn neatly in the answer sheet for full marks. Write each section answer in appropriate subheadings for maximum score.
This is a shared conversation. Sign in to Orris to start your own chat.